Response to letter Re: Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database
database[Title] 2025-12-09
Eur J Cancer. 2025 Dec 4;233:116151. doi: 10.1016/j.ejca.2025.116151. Online ahead of print.
NO ABSTRACT
PMID:41351967 | DOI:10.1016/j.ejca.2025.116151